Bezafibrates Cause Moderate, Reversible Impairment in Renal Function in Patients without Prior Renal Disease

Publisher： Karger

E-ISSN： 1660-2110|100|4|c120-c125

ISSN： 1660-2110

Source： Nephron Clin Pract, Vol.100, Iss.4, 2005-04, pp. : c120-c125

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Impairment of cognitive function associated with hydroxyamylobarbitone accumulation in patients with renal insufficiency

By  

BRITISH JOURNAL OF PHARMACOLOGY (ELECTRONIC), Vol. 45, Iss. 2, 1972-06 ,pp. : 360-367

John Wiley & Sons Inc

Access to resources Recommend Favorite

Prospective Randomized Study Evaluating the Efficacy of the Spherical Adsorptive Carbon AST-120 in Chronic Kidney Disease Patients with Moderate Decrease in Renal Function

By  

Nephron Clin Pract, Vol. 105, Iss. 3, 2006-12 ,pp. : c99-c107

Karger

Access to resources Recommend Favorite

Oxidative Stress in Patients with End-Stage Renal Disease prior to the Start of Renal Replacement Therapy

By  

Nephron Clin Pract, Vol. 98, Iss. 1, 2004-11 ,pp. : c3-c7

Karger

Access to resources Recommend Favorite

Telbivudine is associated with improvement of renal function in patients transplanted for HBV liver disease

By  

JOURNAL OF VIRAL HEPATITIS (ELECTRONIC), Vol. 22, Iss. 7, 2015-07 ,pp. : 574-580

John Wiley & Sons Inc

Access to resources Recommend Favorite

Teriparatide in postmenopausal women with osteoporosis and mild or moderate renal impairment

By Miller P.   Schwartz E.   Chen P.   Misurski D.   Krege J.  

Osteoporosis International, Vol. 18, Iss. 1, 2007-01 ,pp. : 59-68

Springer Publishing Company

Access to resources Recommend Favorite